search Browse Jobs
Medical Evaluation MgrAstraZeneca · China
AstraZeneca logo

AstraZeneca

company page ↗ Visa Sponsoring Company

Medical Evaluation Mgr

✓ This company has sponsored visas before. The posting doesn't say so, but it's still worth applying.

🗓️ Posted 2026-08-18 China Full-time Hybrid Healthcare Medical
💰 Salary Not shared 📊 Market 25,000 GBP–45,000 GBP/mo

About the Company

External Search and Landscape Assessment Monitor the global oncology R&D landscape to identify emerging therapies, technologies, clinical programmes, and potential external partners. Develop and maintain a strong understanding of the China biotech ecosystem, including relevant companies, hospitals and academic institutions. Identify and prioritise external opportunities aligned with oncology portfolio priorities, including combination therapies, clinical trial collaborations and translational research. Build and maintain relationships with external biotech executives, investigators and other relevant stakeholders. Scientific, Clinical, and Strategic Evaluation Evaluate the scientific rationale, pre-clinical and clinical evidence, biomarker strategy, trial design, feasibility, and potential patient impact of external opportunities. Assess the strategic fit, competitive landscape, differentiation potential, and relevance to oncology portfolio priorities. Coordinate cross-functional assessment of scientific, clinical, regulatory, operational, intellectual property, financial, and compliance considerations. Identify key risks, evidence gaps, and diligence requirements, and recommend appropriate next steps. Prepare clear evaluation summaries, recommendations, and decision materials for internal governance and senior stakeholders. Collaboration Development and Management Lead external engagement with biotechnology companies and other potential collaborators

Requirements

  • ● A c a d e m i c / P r o f e ss i o n al Q u a l i f i c a t i o n
  • ● An advanced degree in a relevant discipline, such as an MD, PhD, PharmD, or equivalent degree in life sciences, medicine, pharmacy, public health, or a related field.
  • ● A minimum of three years' relevant experience in the pharmaceutical, biotechnology, or broader life sciences industry is required. Experience in R&D, Medical Affairs, strategy, business development, external partnering, venture investing, investment banking, or management consulting, preferably in oncology, is highly valued.
  • ● Prior experience engaging with external partners and managing complex, cross-functional projects is preferred.
  • ● Te c h ni c a l / S ki l l
  • ● Strong understanding of the oncology R&D landscape, clinical development, and preclinical research.
  • ● Ability to evaluate scientific proposals and translate findings into clear recommendations.
  • ● Strong project management, communication, stakeholder-management, data-interpretation, and presentation skills.
  • ● Fluency in English and Mandarin Chinese, with strong written and verbal communication skills in both languages.
  • ● De s i r a b l e Attribute
  • ● Ability to collaborate effectively across internal functions and with external partners.
  • ● Strategic thinking, sound judgement, adaptability, and the ability to work effectively in a complex and changing environment.
  • ● A high level of integrity and professionalism, with a strong commitment to science and innovation.
  • ● Date Posted 18-8月-2026
  • ● Closing Date 31-10月-2026
  • ● AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.